Evidence map›Paper›PMID 28436935›Full record

ArticleThe Journal of clinical investigation2017

TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury.

Peixiang Lan, Yihui Fan, Yue Zhao, Xiaohua Lou, Howard P Monsour, Xiaolong Zhang, Yongwon Choi, Yaling Dou, Naoto Ishii, Rafik M Ghobrial and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Molecular Mechanism of TRAF6 in Malignant Proliferation of Human NK/T Cell Lymphoma Cell HANK1.Mediterranean journal of hematology and infectious diseases · 2025
    Article
  9. Article
  10. Article
  11. [Research progress on pyroptosis in liver diseases].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Programmed Cell Death in Liver Fibrosis.Journal of inflammation research · 2023
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Peixiang LanImmunobiology and Transplant Science Center, Houston Methodist Research Institute, and.
Yihui FanImmunobiology and Transplant Science Center, Houston Methodist Research Institute, and.
Yue ZhaoImmunobiology and Transplant Science Center, Houston Methodist Research Institute, and.
Xiaohua LouImmunobiology and Transplant Science Center, Houston Methodist Research Institute, and.
Howard P MonsourDepartment of Medicine, Division of Hepatology, Houston Methodist Hospital, Texas Medical Center, Houston, Texas, USA.
Xiaolong ZhangImmunobiology and Transplant Science Center, Houston Methodist Research Institute, and.
Yongwon ChoiUniversity of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Yaling DouImmunobiology and Transplant Science Center, Houston Methodist Research Institute, and.
Naoto IshiiDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai, Japan.
Rafik M GhobrialImmunobiology and Transplant Science Center, Houston Methodist Research Institute, and.
Xiang XiaoImmunobiology and Transplant Science Center, Houston Methodist Research Institute, and.
Xian Chang LiImmunobiology and Transplant Science Center, Houston Methodist Research Institute, and.
Houston Methodist · USTohoku University · JPUniversity of Pennsylvania · US

Funding

Modulation of innate immune cells to create transplant toleranceR01AI080779 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI Xian Chang Li · 2011 to 2026
$5.2M
Control of Treg exhaustion by OX40R01AI106200 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI LI, XIAN CHANG · 2014 to 2025
$4.2M
Regulation of T cell responses to oral antigensR01AI125284 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHOI, YONGWON · 2017 to 2021
$2.0M
NIAID NIH HHS R01 AI080779NIAID NIH HHS R01 AI106200NIAID NIH HHS R01 AI125284
6 · The paper itself

Abstract

Tissue-resident immune cells play a key role in local and systemic immune responses. The liver, in particular, hosts a large number of invariant natural killer T (iNKT) cells, which are involved in diverse immune responses. However, the mechanisms that regulate survival and homeostasis of liver iNKT cells are poorly defined. Here we have found that liver iNKT cells constitutively express the costimulatory TNF superfamily receptor OX40 and that OX40 stimulation results in massive pyroptotic death of iNKT cells, characterized by the release of potent proinflammatory cytokines that induce liver injury. This OX40/NKT pyroptosis pathway also plays a key role in concanavalin A-induced murine hepatitis. Mechanistically, we demonstrated that liver iNKT cells express high levels of caspase 1 and that OX40 stimulation activates caspase 1 via TNF receptor-associated factor 6-mediated recruitment of the paracaspase MALT1. We also found that activation of caspase 1 in iNKT cells results in processing of pro-IL-1β to mature IL-1β as well as cleavage of the pyroptotic protein gasdermin D, which generates a membrane pore-forming fragment to produce pyroptotic cell death. Thus, our study has identified OX40 as a death receptor for iNKT cells and uncovered a molecular mechanism of pyroptotic cell death. These findings may have important clinical implications in the development of OX40-directed therapies.

Indexed as

PyroptosisAnimalsCaspase 1CaspasesCell LineChemical and Drug Induced Liver InjuryEnzyme ActivationMaleMice, Inbred C57BLMice, KnockoutMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinNatural Killer T-CellsNeoplasm ProteinsProtein TransportReceptors, OX40Caspase 1CaspasesMalt1 protein, mouseMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinNeoplasm ProteinsReceptors, OX40Tnfrsf4 protein, mouse

Identifiers

PMID28436935
PMCPMC5451219
OpenAlexW2606696407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.